148 related articles for article (PubMed ID: 38284280)
21. Targeting the CCL2-CCR2 axis in depressive disorders.
Curzytek K; Leśkiewicz M
Pharmacol Rep; 2021 Aug; 73(4):1052-1062. PubMed ID: 34031863
[TBL] [Abstract][Full Text] [Related]
22. Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Iwamoto H; Izumi K; Mizokami A
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297571
[TBL] [Abstract][Full Text] [Related]
23. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
24. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
[TBL] [Abstract][Full Text] [Related]
25. The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials.
Geng H; Chen L; Tang J; Chen Y; Wang L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408846
[TBL] [Abstract][Full Text] [Related]
26. CCR2: A characteristic chemokine receptor in normal and pathological intestine.
Yuan J
Cytokine; 2023 Sep; 169():156292. PubMed ID: 37437448
[TBL] [Abstract][Full Text] [Related]
27. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation.
Xu J; Dong H; Qian Q; Zhang X; Wang Y; Jin W; Qian Y
Behav Brain Res; 2017 Aug; 332():145-153. PubMed ID: 28587818
[TBL] [Abstract][Full Text] [Related]
29. The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine.
Pozzi S; Satchi-Fainaro R
Adv Drug Deliv Rev; 2024 Jun; 209():115318. PubMed ID: 38643840
[TBL] [Abstract][Full Text] [Related]
30. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
[TBL] [Abstract][Full Text] [Related]
31. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
32. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue.
Ito A; Suganami T; Yamauchi A; Degawa-Yamauchi M; Tanaka M; Kouyama R; Kobayashi Y; Nitta N; Yasuda K; Hirata Y; Kuziel WA; Takeya M; Kanegasaki S; Kamei Y; Ogawa Y
J Biol Chem; 2008 Dec; 283(51):35715-23. PubMed ID: 18977759
[TBL] [Abstract][Full Text] [Related]
33. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
34. CCR2 modulates inflammatory and metabolic effects of high-fat feeding.
Weisberg SP; Hunter D; Huber R; Lemieux J; Slaymaker S; Vaddi K; Charo I; Leibel RL; Ferrante AW
J Clin Invest; 2006 Jan; 116(1):115-24. PubMed ID: 16341265
[TBL] [Abstract][Full Text] [Related]
35. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
[TBL] [Abstract][Full Text] [Related]
36. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.
Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW
Diabetes; 2010 Apr; 59(4):916-25. PubMed ID: 20103702
[TBL] [Abstract][Full Text] [Related]
37. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei L; Ren X; Yu H; Zhan Y
Front Immunol; 2021; 12():771210. PubMed ID: 34804061
[TBL] [Abstract][Full Text] [Related]
38. Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open.
Arfaei R; Mikaeili N; Daj F; Boroumand A; Kheyri A; Yaraghi P; Shirzad Z; Keshavarz M; Hassanshahi G; Jafarzadeh A; Shahrokhi VM; Khorramdelazad H
Int Immunopharmacol; 2024 Jun; 135():112328. PubMed ID: 38796962
[TBL] [Abstract][Full Text] [Related]
39. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ
J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity.
Dansereau MA; Midavaine É; Bégin-Lavallée V; Belkouch M; Beaudet N; Longpré JM; Mélik-Parsadaniantz S; Sarret P
J Neuroinflammation; 2021 Mar; 18(1):79. PubMed ID: 33757529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
